1. Please revise the Keywords uniformly to capital or not capital. 2. Page4, Methods and analysis part, please clarify patient centered outcome. 3. Page5, introduction, please give some epidemiology statistics for depression or depression related insomnia 4. Page5, introduction, please show the detailed results(statistics) of meta-analysis for insomnia 5. Page7, Design part: the last sentence "comparing the effects between electroacupuncture, sham acupuncture and standard medication care." Do you mean "comparing the effects between electroacupuncture plus standard medication care, sham acupuncture plus standard medication care and standard medication care alone." 6. Please define hypothesis in design part. 7. Page 9, randomization part: please clarify and revise this part as "Minimization randomization and blinding, Allocation concealment, Implementation and blinding "according to STRICA. 8. Because there is still a debate that acupuncture is a placebo effect due to patient's anticipation, therefore I seriously recommend to add a questionnaire to value the patient's anticipation of acupuncture in this study. 9. Page 11, Treatment group, please revised the acupuncture procedure according to the related part of STRICA. 10. Page 11, control A group, "patients and connected to the needles at Baihui (GV20) and Yintang (GV29). " Is there a real needles at Baihui and Yintang in sham acupuncture group? For the sham acupuncture group, it is better to choose totally different area to place the sham needle compared to acupuncture group, because the touch of skin in the same area of acupoints will also have some effects due to Pibu (skin area of 12 meridian) theory in traditional acupuncture theory. 11. Page 12, control B group: Different drugs will have different effects, and some patients also will take more than 1 or 2 kind of drugs in the same time. Do you think it may be better to limit the kind of drug use for only 1 or 2 kind of defined depression drugs for depression patients? 12. Page12, Primary outcome: please show the name of scale at primary outcome. This is a nicely planned RCT protocol that has benefitted from modification and improvement following the pilot study (ref 15 ). The trial is already at the recruitment stage, and I do not feel that any changes to protocol are warranted. However, there are a number of areas that would benefit from amplification in the text or Discussion.
1. Page 7, lines 11 and 44-48: A requirement for inclusion is stated as "patient complains of insomnia at first visit to doctor". Does this mean during the phone screening, or face to face screening, or on first presentation to a clinic?
Thank you very much for your careful review and enlightening suggestions.
First of all, there are two major ways for us to recruit the participants. One is that the depression patient gives us a phone call first and we will require him/her to the clinic to do a baseline evaluation if he/she complains of insomnia during this phone screening. The other is that the patient directly goes to the outpatient clinic and we will require him/her to do the baseline evaluation if he/she complains of insomnia during this face-to-face screening. Considering the review's advice, we changed this inclusion as "patient complains of insomnia at first screening".
2. Page 7, lines 44-48: Recruitment is via advertisement in outpatient clinics. Are these placed on noticeboards or are they personal advertisement by nurse or clinic doctor? It would be useful to explain why this method was chosen. Noticeboard or website will tend to favour patients who "have interest" and thus an expectation of benefit from acupuncture, while personal recruitment could be biased through nurse/doctor conscious or unconscious selection.
All the participants will be asked to record their changes of dose of drugs during the whole trial, and analysis will be made to determine if these changes would be different among all three groups. The patients will not be withdrawn the trial by changing the dose of the drug.
5. Page 10, Treatment group: What sort of needle is to be used? Is it the active Streitberger or normal acupuncture needles (state type etc)? In Discussion explain the rationale for using the points selected, why the GV pair is chosen for EA, and why 30Hz is used.
For patients in the treatment group, sterile active Streitberger acupuncture needles made by Asiamed GmbH&Co.KG (D98527 Suhl), company that also produces Streitberger sham needles, will be used.
According to the TCM theory, GV20 is the convergent point of six yang meridians as well as the foot Jueyin meridian; it is located on the top of the head, governs yang qi of the body and is the key point of calming mind. GV29 promotes the circulation of qi and blood in the head and restores the function of brain. The electroacupuncture at GV20 and GV29 enhances the effect of soothing nerves. In addition, a functional connectivity MRI (fcMRI) study suggested that EA at GV20 and GV29 may have effect on mental disorders. The experiment using fcMRI to identify the key cerebral functional region affected by EA at GV20 and GV29 illustrated that the center of the cerebral network changed from the caudate nucleus to the parahippocampal gyrus and hypothalamus. The network centered on the parahippocampal gyrus and hypothalamus primarily functioned in somatic movement, sensation, vision, hearing and language. This finding may indicate a mechanism for treating depression using EA at GV20 and GV29.
A frequency-specific neurochemical response in the central nervous system may be related to differential response of the body to low-and high-frequency EA stimulation and different peripheral and central pathways. Previous research found that low frequency EA could be useful in clinical settings to manage pain while high-frequency stimulation has more potent effects on 5-HT activity. We chose 30Hz based on an acupuncture textbook: Acupuncture and moxibustion technique, People's medical publishing house, Beijing, 2012.6, page 158.
We have added the content above in the discussion part accordingly suggestion.
6. Page 10, Control A: Zhang et al (PLoS One 2015; 10(11): e0140825) state that "meta-analysis does not support the notion of either the Streitberger or the Park device being inert control interventions". This needs to be mentioned in the discussion to explain that the Streitberger sham needle probably has some physiological effect and is thus unlikely to be a true placebo. Additionally its pricking and pressure sensations are similar to acupressure which is reported by Yeung et al (Sleep Medicine 2012; 13(8): 971) in a review of acupressure RCTs as an effective treatment for insomnia.
We agree with the review's point of view. It should be admitted that a perfect placebo intervention for real acupuncture exerts no physiological effects. In our study, we planned to explain to the patients that they will be randomly into one of three groups and receive different interventions before treatment. If the blinding method is in successful implementation, patients in SA group wouldn't notice the group assignment. If patients in SA group have no feeling when the needle tip touching the skin, they will possibly guess the group assignment and it will absolutely affect the blinding method. Compared with other sham acupuncture method, we regarded that the Streiberger sham needling as a better one.
Talking about the Yeung's trial, the result that there was no difference between acupuncture and the Streitberger needle's pricking and pressure sensation wasn't quite convincing. We achieved different result with blunt needle tip as sham acupuncture method in our previous study (Yin X, Gou M, Xu J, et al. Efficacy and safety of acupuncture treatment on primary insomnia: a randomized controlled trial.
Sleep Medicine 2017). The Yeung's trial also had some limitations include the frequency of the acupuncture treatment and the small sample size. Besides, one important aim for us to do this trial is to verify the effects of acupuncture on depression-related insomnia with a well-designed RCT.
7. Page 11, Primary outcome: Typing error! PSQI omitted.
Sorry for not being careful. We have corrected the error.
8. Page 15, paragraph 2: This trial conducted in a major city may not be transferrable to rural community insomnia.
We agree that the prevalence of insomnia is much higher in urban area than that in rural area. However, this does not mean the effect of acupuncture would be different in these two different areas. The protocol reported a well-designed RCT which wants to evaluate the efficacy and safety of electroacupunture for depression-related insomnia. However, there are certain things in the manuscript that are not clearly reported. Some questions or comments as follows.
1. It's proposed reporting the protocol in accordance with SPIRIT 2013, and to use the checklist of SPIRIT to check the reporting in the manuscript.
Thank you for your constructive comments.
We have used SPRIT as the checklist for our study and we have uploaded the file. Sorry for the careless mistake and we have corrected the reference. 4 . Although the sample size of 270 cases may meet the requirements of testing the preset differences, the calculation of sample size still does not in accordance with the purpose of superiority test. Has the minimal clinically important difference of PSQI score been considered in the sample size estimation? Or, how much the PSQI score change to baseline can be defined as a response event? It is even more reasonable to estimate the sample size with the event rate. In addition, the symbols in the formula have to be explained if the formula is available.
We have considered the minimal clinically important difference of PSQI score and assumed 0.2 of the PSQI difference is the superior effect. We have revised the sample size calculation part, explaining the new formula we use after discussion (seen on page 8).
5. TESS scale is used to record adverse events, not to evaluate adverse reactions. The relationship of adverse events with drugs or acupuncture requires further assessment by causality criteria. In the Adverse events section, it may need more details to mention the safety assessment.
We agreed with the reviewer. We will further assess the AEs associated with drugs or with acupuncture.
These AE data will be assessed in terms of severity and causality, and the incidence will also be determined. The 3-point grading categories were applied: grade 1, mild, grade 2, moderate, grade 3, severe or medically significant. The causality categories used were certain, probable/likely, possible, unlikely, conditional/unclassified and unassessable/unclassifiable (The use of the WHO-UMC system for standardized case causality assessment. 2012). The incidence of AEs was presented as the number of AEs per number of acupuncture sessions (%).
We have added the content above in the Adverse events section.
6. Regarding to the Statistical analysis section, it is too simple. I think that a brief statistical analysis plan should be mentioned in which include primary analysis, main comparisons, missing data processing and co-variate adjustment etc.
Thanks again for all your valuable suggestions and we have revised the Statistical analysis section.
"The primary analysis will be a comparison of the changes of patients' PSQI score among three groups at 8 weeks after inclusion (comparison of the primary endpoint). The secondary analysis will be performed to assess the changes of the SE, TST and SA recorded in the actigraphy, as well as the HAMD scores and SAS scores from baseline to 8 weeks after inclusion. We will also count the number of patients who increase or decrease the drug dose, and then analyze the differences among three groups. All analyses will be performed on the intention-to-treat (ITT) population of participants who have at least one treatment. Missing data will be handled using the multiple imputation method, on the assumption that values at each time point follow a specific distribution calculated by the computer software R V.3.5. We will also perform a complete-case analysis without imputation of missing data, to find out if the results are consistent. Data analyses will be performed with the use of the statistical software SPSS V.20.0. The t-test will be used to compare the measurement data between either two groups from the baseline to 6 months follow-up; the rank sum test will be used for ranked data while the test will be used to analyze categorical data. The significance level that will be used for statistical analysis with 2-tailed testing will be 2.5%. Data values will mainly be presented as Mean±SD."
Reviewer: 3 Reviewer Name: Zishan Gao Institution and Country: Nanjing University of Chinese Medicine, Nanjing, China.
Please state any competing interests or state 'None declared': None declared Please leave your comments for the authors below This protocol mainly describe a multi-center randomized control trial of acupuncture for insomnia due to depression. In summary, this trial may be uncover important the efficacy and safety results of acupuncture for insomnia due to depression. However, some of methodology parts of this protocol are not in accordance with STRICA and may cause possible bias. Thus, I may suggest authors further major revised this article according to the following suggestions:
1. Please revise the Keywords uniformly to capital or not capital.
We have revised the keywords uniformly. 2. Page4, Methods and analysis part, please clarify patient centered outcome.
The PSQI score is used to evaluate patients' sleep quality. The HAMD score is used to evaluate patients' depressive mood and the SAS score is used to evaluate patients' anxiety state. The dose dairy is used to record patients' daily dose of drugs.
3. Page5, introduction, please give some epidemiology statistics for depression or depression related insomnia.
According to the reviewer's suggestion, we have added the epidemiology statistics for depression and its related insomnia in the introduction part.
"The global point prevalence of MDD is 4.7%, and the estimation of a 12-month cumulative incidence of depression in China is 5.23%". 5. Page7, Design part: the last sentence "comparing the effects between electroacupuncture, sham acupuncture and standard medication care." Do you mean "comparing the effects between electroacupuncture plus standard medication care, sham acupuncture plus standard medication care and standard medication care alone."
Yes. We have revised this sentence for clarity. 6. Please define hypothesis in design part.
The hypothesis of the study is "that acupuncture plus standard care would be superior than sham acupuncture plus standard care or standard care alone in treating depression related insomnia". Please see page 5, line 13. 7. Page 9, randomization part: please clarify and revise this part as "Minimization randomization and blinding, Allocation concealment, Implementation and blinding "according to STRICA.
We have revised this part. 8. Because there is still a debate that acupuncture is a placebo effect due to patient's anticipation, therefore I seriously recommend to add a questionnaire to value the patient's anticipation of acupuncture in this study.
We agree with the review and will use the Vincent's four question of expectation to value the patients' anticipation of acupuncture in this study.
9. Page 11, Treatment group, please revised the acupuncture procedure according to the related part of STRICA.
We have revised the acupuncture procedure following STRICA guidelines.
10. Page 11, control A group, "patients and connected to the needles at Baihui (GV20) and Yintang (GV29). " Is there a real needles at Baihui and Yintang in sham acupuncture group?
For the sham acupuncture group, it is better to choose totally different area to place the sham needle compared to acupuncture group, because the touch of skin in the same area of acupoints will also have some effects due to Pibu (skin area of 12 meridian) theory in traditional acupuncture theory.
The answer for the reviewer's first question is yes. We have attached the figure of Streitberger sham needles with the protocol.
This picture shows how the Streitberger sham needle which can be stuck to the skin works. There are needles with blunt tip retained during the treatment. Besides, we need to connect the electroacupuncture apparatus to GV20 and GV29 though without current which cannot be realized without needles.
We will use the Streitberger sham device in which a needle with blunt tip will be place on the skin but will not be inserted. For the location of the sham points, it might be difficult to blind patient if it is too obvious in an irrelevant area. Furthermore, in our previous study, we found this device produced little effect as compared to the real needling. Therefore, we are confident we will produce minimum nonspecific effect. 11. Page 12, control B group: Different drugs will have different effects, and some patients also will take more than 1 or 2 kind of drugs in the same time. Do you think it may be better to limit the kind of drug use for only 1 or 2 kind of defined depression drugs for depression patients?
As mentioned in the inclusion criteria, "patients who have taken same drugs for more than 4 weeks or patients who don't take medicine" can be recruited. There are various kinds of anti-depressants and sedative hypnotics, including the most commonly used selective serotonin reuptake inhibitors (SSRIs) and benzodiazepines. There are different causes and symptoms of every patients' depression and insomnia and then their psychiatrists gave patients different kinds of drugs. We have to allow the patient takes whatever they have been taking but we will document all the medicines and their dosage.
12. Page12, Primary outcome: please show the name of scale at primary outcome.
Sorry for the mistake and we have added the primary outcome "Pittsburgh Sleep Quality Index (PSQI)". The specific statistical measure we will apply based on the outcomes we get. If there is imbalance baseline or too much secondary variables, we may use ancova to evaluates whether the means of a dependent variable are equal across levels of the treatment, while statistically controlling for the effects of other continuous variables that are not of primary interest.
All analyses will be performed on the intention-to-treat (ITT) population of participants who have at least one treatment. Data analyses will be performed with the use of the statistical software SPSS20.0. We have revised the statistical analysis part according to the reviewer's advice. please see page 13, the "Statistical analysis part". 14. Professor Lixin Lao is a renowned methodology expert, but how could him monitor this trial since he is mainly in Hongkong? Please clarify the quality control process. This question is answered by Prof. Lixing Lao:
As an experienced clinical researcher, Prof. Lixing Lao has been our collaborator for the past many years and he has contributed in the design of the study and he will further participate in and monitor the trial via multiple means of communication, such as face-to-face meetings when he travels to Shanghai, video-conference via WeChat or Skype, and audio conference via telephone or WeChat. Furthermore, email exchange in always a most efficient way for communication. The distance no longer the issue in the modern world.
15. Please give a main graph to show the process of this trial.
A study flowchart has been added.
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Thank you for adding explanation to your text following the peerreview questions and suggestions. I feel this is now a well planned and discussed protocol and expect the trial to proceed successfully. Good luck!
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